Retagliptin
Intermediates
- Retagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor developed for the treatment of type 2 diabetes by increasing incretin levels to improve insulin secretion and blood glucose control. Reference standards of Retagliptin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Retagliptin
[catalogue_number] => PA 18 1850000
[category_ids] => ,82,80,78,71,70,
[chemical_name] =>
[weight] => 464.37
[form] => C19H18F6N4O3
[cas] => 1174122-54-3
[pslug] => 1174122-54-3-retagliptin-pa181850000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 18 1850000
Molecular Formula : C19H18F6N4O3
Molecular Weight : 464.37